Upcoming Medical Conferences in New York CitySearch Criteria : United States of America New York City
Oct 15 - 16, 2019 | CH 12.00 | New York City, New York
Electronic Fetal Monitoring Certification Review is organized by New York State Nurses Association (NYSNA) and will be held from Oct 15 - 16, 2019 at NYSNA Westchester Office, New York City, New York, United States of America. Accreditation: This program has been awarded 12.0 CHs through the New York State Nurses Association Accredited Provider Unit. The New York State Nurses Association is authorized by IACET to offer 1.2 CEUs for this program. Course Description: The intent of this curriculum is to prepare the healthcare practitioner with the knowledge and skills to provide a comprehensive, systematic, evidence-based approach to standardized intrapartum fetal heart rate interpretation and management that reflects current standards of clinical practice. This program is offered to those clinical practitioners who want to be able to articulate a comprehensive, thoughtful, reasonable fetal heart rate management plan, and communicate to their patients and peers information regarding fetal status via fetal heart rate monitoring that is appropriate and factually accurate. Course Objectives: The purpose of this activity is to enable the learner to: • Review the nurse’s role in management of Fetal Heart Rate Monitoring methods. • Identify the underlying physiology that impacts on electronic fetal heart monitoring. • Recognize the various patterns of fetal heart tracing and the appropriate nursing intervention. • Discuss common complications related to selected abnormal fetal heart patterns and the nurse’s role. • Identify methods of fetal surveillance other than fetal heart monitoring tracings. • Discuss the specific professional issues related to fetal heart monitoring. • Identify several strategies to increase success on the examination Additional details will be posted as soon as information is available.
Oct 16 - 19, 2019 | USD $750 | New York City, New York
Digestive Disease Interventions (DDI) 2019 is organized by American Society of Digestive Disease Interventions (ASDDI) and will be held from Oct 16 - 19, 2019 at Crowne Plaza Times Square Manhattan, New York City, New York, United States of America. Description: Digestive Disease Interventions (DDI) is the first and only forum in the US devoted to the assembly of interventional radiologists, gastroenterologists, oncologists, surgeons, and allied fields with a special interest in minimally invasive percutaneous therapies of the GI tract organs. Jointly-sponsored by the American Society of Digestive Disease Interventions and the Society of Interventional Radiology, the 6th Annual Meeting in New York City will assemble renowned experts from around the nation to speak on a range of topics including: • Interventional oncology • Hepatopancreatobiliary disorders • Portal hypertension • Gastrointestinal hemorrhage • Mesenteric ischemia • Obesity • Enteral nutrition • Gastrointestinal obstruction DDI will also feature a Simulation Day at Weill Cornell Medicine’s Skills Acquisition & Innovation Laboratory. A multidisciplinary perspective… One of the key goals of this meeting is the inclusion of speakers from pertinent fields such as gastroenterology, oncology, surgical oncology, GI surgery, and hepatology, in order to provide an unbiased and comprehensive perspective of these topics that will enhance your understanding of the pathology and treatment of digestive diseases.
Oct 16 - 19, 2019 | New York City, New York
American Shoulder And Elbow Surgeons (ASES) Annual Meeting is organized by American Shoulder and Elbow Surgeons and will be held during Oct 16 - 19, 2019 at Sheraton New York Times Square Hotel, New York, United States of America. The target audience for this medical event is Surgeons. Additional details will be posted as soon as they are available.
Oct 16 - 17, 2019 | New York City, New York
2019 Association for Value-Based Cancer Care (AVBCC) Summit is organized by Association for Value-Based Cancer Care (AVBCC) and will be held from Oct 16 - 17, 2019 at New York Athletic Club, New York City, New York, United States of America. Conference Description: This is a prime opportunity to gain a thorough understanding of the evolution of the value equation as it relates to cancer therapies and discover how to implement, improve, and sustain your company or institution, while improving access for patients and ultimately patient care. Reasons to Attend: • Stay competitive in the ever-changing field of oncology participating in sessions on topics including Health Policy, Telemedicine, Practice Management, Oncology Specialty Pharmacy and Supply Chain, and more. • Learn from stakeholders within the cancer care spectrum, including practitioners, pharmacists, payers, and policymakers to improve patient care and maximize patient access and outcomes through care coordination. • Network with nationally recognized experts, faculty speakers, panelists, key opinion leaders, C-suite executives, and managers to exchange best practices in advanced value-based performance and quality measures in cancer care. Additional details will be posted as soon as they are available.
Oct 17 - 18, 2019 | CME 12.25 | USD $225 | New York City, New York
The Sixth Annual Cardiovascular Summit 2019: A Multidisciplinary Team Approach is organized by Columbia University Irving Medical Center (CUIMC) and will be held from Oct 17 - 18, 2019 at NewYork Presbyterian/Columbia University Medical Center, New York City, New York, United States of America. Target Audience: This activity is designed for primary care physicians, cardiologists, interventional cardiologists, vascular, thoracic and cardiac surgeons, general surgeons, internists, intensivists, anesthesiologists, podiatrist, cardiac and vascular NPs and PAs, RNs, physical therapists, and other medical professionals involved in the evaluation, diagnosis and/or management of patients with cardiovascular disease. Accreditation: Physicians Amedco LLC designates this live activity for a maximum of 12.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistants AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditsTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 12.25 AMA PRA Category 1 CreditsTM for completing this activity. Program Overview: Cardiovascular Summit 2019 is the Sixth Annual Cardiovascular Therapy Course, hosted by NewYork-Presbyterian/Columbia University Irving Medical Center. This premier two-day course represents a unique multidisciplinary collaboration between cardiologists, vascular, and cardiac surgeons, allowing for a truly comprehensive approach to the management of an aortic and cardiovascular disease. Lectures will be given by internationally recognized experts who will address the newest clinical trials published in the field, and review the standard and emerging treatments for patients with cardiovascular diseases. Didactic sessions, case presentations, and interactive discussions will engender learning and improvement in the management of patients with the full spectrum of cardiovascular disease. Learning Objectives: • Discuss basic and advanced knowledge related to aortic aneurysm as well as surgical and endovascular aortic therapies • Explain rapidly changing care for treatment of aortic stenosis, mitral and tricuspid regurgitation • Describe existing and emerging advanced interventions for coronary artery disease, cardiogenic shock • Learn contemporary management of peripheral vascular disease Additional details will be posted as soon as they are available.
Adolescents and Young Adults with Neuromuscular Conditions: Moving Forward From Pediatric- to Adult-Based Health Care System
Oct 17, 2019 | New York City, New York
Adolescents and Young Adults with Neuromuscular Conditions: Moving Forward From Pediatric- to Adult-Based Health Care System is organized by New York University (NYU) School of Medicine and will be held on Oct 17, 2019 at NYU Langone Health, New York City, New York, United States of America. Target Audience: Medical Doctors (pediatric and adult): orthopedist, physiatrist, neurologist, neurosurgeon, pulmonologist, GYN, pediatrician, family doctor, internal medicine, hospitalist, genetics Dentistry: pediatric and adult Rehabilitation (pediatric and adult): PT, OT, Speech Therapy, vocational therapist Nursing (pediatric and adult): out-patient clinic, community, school Nurse Practitioners (pediatric and adult): orthopedic, physiatry, neurology, neurosurgery, pulmonology, GYN, pediatrics, family medicine, internal medicine, hospitalist, genetics Physician’s Assistant (pediatric and adult): orthopedic, physiatrist, neurologist, neurosurgeon, pulmonologist, GYN, pediatrics, family medicine, internal medicine, hospitalist, genetics Social Work Administrators Community Workers Students Course Description: This is a one day CME course focuses on the current state of Transition (from pediatric- to adult-based health services) of care for patients with neuromuscular conditions locally and nationally. It will articulate the medical and psychosocial needs and available resources for transition of care. The educational program will include a dialogue between patients and caregivers and health care providers (HCP) and community leaders to discuss unique issues and to design viable solutions. Overall, the aim is to engage interprofessional HCP to deliver lifespan care to patients with childhood-onset neuromuscular conditions including their families and/or caregivers. Educational Objectives: After participating in this activity, clinicians should be able to: • Design individualized care plans utilizing current evidence an implement delivery of care to children and adults with CNMC • Identify interventions for children with CNMC that promote participation, learning, life skills, and/or independence • Develop strategies to prepare patients for independently managed adult care Additional details will be posted as soon as they are available.
Comprehensive Spine Course is organized by New York University (NYU) School of Medicine and will be held on Oct 18, 2019 at NYU Langone Health, New York City, New York, United States of America. Target Audience: Physiatrists, Neurologists, Pain Management Physicians, Rheumatologists, Sports Medicine Physicians, Primary Care Physicians, Internists, Orthopedic Surgeons, Physical Therapists, Chiropractors, Nurses, Athletic Trainers caring for patients with spinal disorders. Course Description: The program will focus on the application of practical experience and didactic knowledge to improve the practitioner's knowledge base and diagnostic therapeutic accuracy. Patients with spinal related complaints end up in offices of practitioners of diverse specialties. This one-day course is a comprehensive review of four stages of the spine care continuum: examination, evaluation and diagnosis; therapeutic interventions; spinal injections; surgical interventions. Each area will focus on common pitfalls, application of practical experience, and comprehensive understanding of evidence based care. Patients with any of the disease states of the spine pathology spectrum require a vast range of treatment modalities and as a result, health care professionals require diagnostic tests that necessitate evaluation, interpretation and intervention. These may be acute, chronic or both. Many practitioners seek the latest knowledge and experience to properly handle the differential diagnosis and select appropriate intervention. Physicians need to appreciate the major decision-making surrounding the medical management of spinal disorders. It is imperative that they incorporate and integrate latest knowledge and updated practical experience on the clinical presentation, natural history and management for spinal disorders. Spine patient care can be improved by incorporating innovative knowledge of conservative, surgical, alternative, and rehabilitative treatments into day-to-day practice. Educational Objectives: After participating in this activity, clinicians should be able to: • Develop a systematic method for physical examination of their patients with reported spinal disorders • Identify specific mediators of back and neck pain. They will compare various nonoperative methods of relieving back pain (exercise, drugs, acupuncture, injections, therapy, TENs, ultrasound, other complementary methods). • Establish a screening strategy using the single or combined objective electrophysiological and imaging tools to correctly identify spine degenerative diseases and deformities in their spine patients • Establish a screening strategy using the single or combined objective electrophysiological and imaging tools to correctly identify spine degenerative diseases and deformities in their spine patients • Recognize when it’s best to treat patients non-operatively versus when to refer a patient for surgical consultation • Describe the type of surgery performed on their patient and that surgery’s implications on postoperative care. Develop a postoperative management plan. • Identify and treat patients with history of fragility fractures and patients who have high fracture risk. Know the options for the treatment of low bone mass. Additional details will be posted as soon as they are available.
Oct 18 - 19, 2019 | CME 12.50 | USD $499 | New York City, New York
Perspectives in Thoracic Oncology - The premier conference for annual updates in lung cancer is organized by Imedex and will be held from Oct 18 - 19, 2019 at New York Marriott Marquis, New York City, New York, United States of America. The target audience for this medical event is designed to meet the educational needs of medical and radiation oncologists, thoracic surgeons, nurses, diagnostic radiologists, pathologists, pulmonologists, researchers, and other healthcare professionals interested in the care and treatment of patients with thoracic malignancies. This CME Conference has been approved for a maximum of 12.50 AMA/CME Credits. Conference Description: For 24 years, this premier gathering of healthcare professionals involved in the treatment of lung cancer continues to differentiate itself from other meetings in the field of thoracic oncology by offering a broad scope of topics essential for practicing oncologists and clinicians. The conference offers a comprehensive update on lung cancer screening and smoking cessation, biomarker testing, management of lung cancer across the spectrum of disease stages, and NSCLC, SCLC, mesothelioma, and thoracic tumors. Conference Highlights: • Liquid biopsy • Lung cancer screening • Smoking cessation • Locally advanced NSCLC • Early-stage non-small cell lung cancer (NSCLC) • Adjuvant therapy • Mesothelioma • Squamous cell carcinoma • Thymic tumors • The new staging system • Advanced NSCLC • Supportive therapy • Biomarkers and targeted therapy • Immunotherapy Learning Objectives: After attending Perspectives in Thoracic Oncology 2019, participants should be able to: • Describe the impact of lung cancer staging system revisions, molecular testing guideline updates, novel imaging and diagnostic techniques, and the role of liquid biopsy/cell free DNA on patient evaluation practices • Review the current and emerging clinical data regarding the treatment NSCLC that harbor genetic mutations such as EGFR, ALK, ROS1, and less commonly ERBB2, HER2, BRAF, KRAS, MET, TRK, and RET • Determine the clinical relevance of emerging efficacy and safety data from trials evaluating targeted therapies and immune checkpoint inhibitors (alone or in combination) for NSCLC, SCLC, mesothelioma, and less common thoracic malignancies • Evaluate the role of current and emerging biomarkers as predictive indicators for treatment selection and patient response • Translate the latest evidence regarding molecularly targeted agents, immunotherapies, and predictive biomarkers to informed and personalized NSCLC treatment plans Speaker: Conference Chair: Corey J. Langer, MD, Abramson Cancer Center, University of Pennsylvania Time: 8:00 am to 4:00 pm
Oct 18, 2019 | CME 6.25 | USD $1499 | New York City, New York
ACP & Stem Cell Therapies for Pain Management is organized by Empire Medical Training (EMT), Inc and will be held on Oct 18, 2019 at The Westin New York at Times Square, New York City, New York, United States of America. Target Audience: This activity has been designed to meet the educational needs of Health Care Practitioners involved in the care of the patients with Aesthetic requests. Accreditation: Physician Credit Medical Education Resources designates this live activity, for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Credit Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This CE activity provides 6.25 contact hours of continuing nursing education. Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for [6.25] contact hours. Description: Autologous Conditioned Plasma (ACP) aka PRP has numerous corrective pain management indications for patients that are non-responsive to conventional treatments. ACP injections have been utilized with a number of medical conditions including tendinopothies, joint pain, arthritis, and sports medicine applications. In this 1-Day course, you will receive extensive training in the harvesting and administration of ACP including the use of biologics (concentrated growth factors) such as amniotic tissue as well as stem cells derived from adipose cells for use in patients. Enhance patient care and realize the benefits of using and offering these regenerative therapies within your practice and create new revenue streams and greater patient satisfaction. This evidence-based course will prepare attendees to diagnose, harvest, and administer these regenerative therapies in an office setting. These interventional procedures can be performed safely within an office setting (clean procedure | aseptic procedure) and can be used in combination with conventional treatments without complications and to the benefits of patients. Autologous Conditioned Plasma (PRP) can be used as a stand-alone treatment effectively or combined with Allograft CGF (Concentrated Growth Factors) to compliment traditional pain management therapies. Typically, ACP injections are cash basis procedures and the average cost to patients is approximately $600 - $800 per injection cycle (before biologics) or treatment in pain management applications. Program Overview: The ACP & Stem Cell Therapies for Interventional Pain Management seminar is a combination lecture and workshop where learners will participate in didactic lectures in the morning followed by hands on training in the afternoon. Learners will understand how to utilize the latest therapies in relation to ACP, Amniotic Derivative Products, BMAC, ASC, and Umbilical Cord Blood (UCB). The purpose of the training is to help learners provide enhanced patient care to those who present themselves with various medical and pain management conditions. Target audience includes healthcare professionals for procedures which have not been taught in their previous medical education. Learning Outcome: To provide learners with a foundation for following correct standards of care and acquire the necessary technical skills to perform each of these procedures correctly and by adhering to published protocols and guidelines Educational Objectives: • Practice procedures such as ACP (Platelet Rich Plasma) and Amnio Products (Stem Cells) competently, safely, and effectively for their patient. Each participant will understand and learn how to avoid risks and associated complications. • Apply generally accepted protocols for the administration of Platelet Rich Plasma for various chronic and sub-acute medical conditions. • Describe the mechanism of action of Platelet Rich Plasma and the Amnio products available and differences between the product characteristics, patient preferences, managing expectations, and after care for follow up after the interventional pain injection procedures. • Identify who is a candidate for Platelet Rich Plasma (ACP) Therapies and the use of the additive Amniotic derived products available, patient benefits, and long-term expectations and additional treatments dependent upon patient presentation. Increase patient awareness and offer enhanced patient care in relation to this non-invasive, non-surgical procedure. Additional details will be posted as soon as they are available.
Oct 18, 2019 | New York City, New York
Dietary and Lifestyle Strategies for Cardiovascular Risk Reduction 2019 is organized by New York University (NYU) School of Medicine and will be held on Oct 18, 2019 at NYU Langone Health, New York City, New York, United States of America. Target Audience: Physicians (cardiologists, internists, general and family practice providers, endocrinologists, physiatrists, oncologists and any physician with an interest in cardiovascular risk reduction), advanced practice providers, medical trainees, nurses and dietitians. physical therapists, occupational therapists and other allied health care professionals with an interest in the prevention of heart disease. Course Description: This one day course focuses on strategies to reduce risk for cardiovascular disease through lifestyle approaches for risk factor management. Diet and lifestyle choices are crucial components of preventive cardiology in the development and progression of cardiovascular disease (CVD) and related comorbidities such as hypertension, diabetes and dyslipidemia. Clinicians will be educated on benefits of prescribing various diets, meditation, supplements, exercise, and sleep hygiene. Speakers will cover weight loss options for cardiovascular health, including pharmaceutical treatments and bariatric surgical options. Attendees will also learn about the role of inflammation in CV risk and how certain autoimmune conditions affect inflammation and heart disease. Exercise is a significantly under-utilized modality in the management of cardiovascular disease and its risk factors. The literature supports the concept of exercise as medicine and its use for risk factor management, primary and secondary cardiac event prevention, and management of established cardiovascular disease. This course will cover the ideal exercise prescription to prevent cardiovascular disease and to recover from a cardiac event through cardiac rehabilitation. Emerging concepts regarding exercise frequency and intensity will be covered. Attendees will understand and appreciate the psychosocial impact of cardiac disease and management through cardiac rehabilitation as well as the impact of nutrition on exercise performance. The impact of exercise on immune function, sarcopenia and oncologic disease will be discussed. New clinical research and a review of current evidence will provide the attendees with the latest information to help their patients achieve optimal health through and exercise, diet and integrative medicine strategies. Educational Objectives: After participating in this activity, clinicians should be able to: • After participating in this activity, clinicians should be able to describe how medically supervised diets, pharmaceutical therapies and surgical interventions effect risk for cardiovascular disease and co-morbidities • After participating in this activity, clinicians should be able to describe how the Mediterranean, plant based/whole food and KETO diets can be used in the primary prevention of cardiovascular disease as well as what the current sets of guidelines recommend • After participating in this activity, clinicians should be able to describe how the duration and quality of sleep effects cardiovascular disease risk and means to assess for and treat sleep apneas closely tied to multiple CV comorbidities • After participating in this activity, clinicians should be able to describe the outcomes data from the the REDUCE-IT trial and the implications on clinical care • After participating in this activity, clinicians should be able to describe the role that inflammation plays in chronic illness and the current research on the anti or proinflammatory effects of select foods, diet patterns and lifestyle • After participating in this activity, clinicians should be able to describe best practices for cardiac rehabilitation (CR) with reference to the Million Hearts Cardiac Rehabilitation Change Package (CRCP) highlighting patient education strategies throughout the continuum of care • After participating in this activity, clinicians should be able to describe the development of an individualized exercise program, using the FITT formula, as part of a healthy lifestyle and in patients with cardiovascular disease with emphasis on dietary changes to optimize exercise outcomes • After participating in this activity, clinicians should be able to Recognize the impact of exercise in prevention and management of oncologic disease and oncological rehabilitation as well as the impact of exercise on immune function • After participating in this activity, clinicians should be able to discuss the impact of ageing on exercise with emphasis on sarcopenia highlighting prevention and treatment options • After participating in this activity, clinicians should be able to identify how stress contributes to cardiovascular disease, describe the current evidence for various stress-reduction lifestyle therapies and discuss the impact of mind-body medicine and integrative cardiology/cardiac rehab on participation and retention in cardiac rehab programs. Additional details will be posted as soon as they are available.